• 11-01-2021

DeepIntent Survey Reveals That Pharmaceutical Advertising Motivates Patients to Research Treatment and Medication Options

DeepIntent surveyed 1,244 U.S. patients in August 2021 about their attitudes toward pharmaceutical ads and whether they find them relevant.

In this article, Pharmaceutical Executive Magazine shares key takeaways from the survey revealing how advertising motivates patients to research their treatment and medication options. DeepIntent’s CEO Chris Paquette also shares the opportunities healthcare marketers can act on as a result of this research.

Read more here.

More News

Article
Why DTC Pharmaceutical Advertising Shouldn’t Be Banned
6-18-2025
Last week, a new bill called the “End Prescription Drug Ads Now Act” was introduced in Congress, aiming to ban nearly all direct-to-consumer (DTC)...
Read More
Article
Why Data Choice Matters in Pharmaceutical Advertising
6-12-2025
In pharmaceutical marketing, data is the foundation for strategy, targeting, and measurement. As marketing becomes increasingly data-driven—and more data becomes available than ever before—the...
Read More
Article
Empowered Voices: Women Driving Innovation in Healthcare Marketing
5-23-2025
AdLab 2025’s final panel brought together top healthcare marketing leadership to discuss the groundbreaking, women-led innovations shaping our industry, and how women leaders are...
Read More